bioMérieux S.A. (EPA:BIM)

France flag France · Delayed Price · Currency is EUR
124.70
-1.30 (-1.03%)
Jul 30, 2025, 5:35 PM CET
-1.03%
Market Cap14.86B
Revenue (ttm)3.98B
Net Income (ttm)432.20M
Shares Out117.93M
EPS (ttm)3.64
PE Ratio34.62
Forward PE27.87
Dividend0.90 (0.71%)
Ex-Dividend DateJun 9, 2025
Volume99,832
Average Volume106,980
Open126.00
Previous Close126.00
Day's Range124.70 - 126.20
52-Week Range94.90 - 127.30
Beta0.48
RSI64.14
Earnings DateSep 4, 2025

About bioMérieux

bioMérieux S.A. develops and markets in vitro diagnostic solutions for infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers CHROMID RANGE, a chromogen culture media; RAPIDEC CARBA NP biochemical test for the detection of carbapenemase producing bacteria; air, surface, and water monitoring systems; BACT/ALERT VIRTUO or 3D, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction system; BIOFIRE SPOTFIRE Lowplex PCR point-of-care system; VITEK MS, a mass spectrometry system; VI... [Read more]

Sector Healthcare
Founded 1963
Employees 14,754
Stock Exchange Euronext Paris
Ticker Symbol BIM
Full Company Profile

Financial Performance

In 2024, bioMérieux's revenue was 3.98 billion, an increase of 8.31% compared to the previous year's 3.67 billion. Earnings were 432.20 million, an increase of 20.86%.

Financial Statements

News

bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2021 Results - Earnings Call Transcript

bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2021 Results - Earnings Call Transcript

3 years ago - Seeking Alpha

bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q3 2021 Results - Earnings Call Transcript

bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q3 2021 Results - Earnings Call Transcript

4 years ago - Seeking Alpha

bioMérieux: Pioneering In Vitro Diagnostics

bioMérieux is a leading developer and producer of in vitro diagnostic solutions with a focus on infectious diseases. The Company has a solid financial structure to support growth.

4 years ago - Seeking Alpha

bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2020 Results - Earnings Call Transcript

bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2020 Results - Earnings Call Transcript

4 years ago - Seeking Alpha